Holen Sie sich die Stockscreener-App
38.64
2.62%
-1.04
Handel nachbörslich:
39.30
0.66
+1.71%
Lenz Therapeutics Inc Aktie (LENZ) Neueste Nachrichten
News impact scoring models applied to LENZ Therapeutics Inc.Market Sentiment Report & Real-Time Buy Signal Notifications - Newser
Real time breakdown of LENZ Therapeutics Inc. stock performanceQuarterly Market Summary & Verified Momentum Watchlists - Newser
Analyzing LENZ Therapeutics Inc. with risk reward ratio charts2025 Valuation Update & Trade Opportunity Analysis Reports - Newser
How to build a dashboard for LENZ Therapeutics Inc. stockQuarterly Market Summary & High Return Stock Watch Alerts - Newser
Relative strength of LENZ Therapeutics Inc. in sector analysis2025 Key Highlights & Detailed Earnings Play Alerts - Newser
LENZ Therapeutics Inc. stock outlook for YEARGold Moves & Weekly Chart Analysis and Guides - Newser
What MACD and RSI say about LENZ Therapeutics Inc.Market Performance Summary & Verified Chart Pattern Trade Signals - Newser
Using data tools to time your LENZ Therapeutics Inc. exitEarnings Recap Summary & Reliable Entry Point Trade Alerts - Newser
Has LENZ Therapeutics Inc. Stock Ever Crashed Historical Volatility ReviewJuly 2025 Earnings & Reliable Entry Point Alerts - Newser
Detecting support and resistance levels for LENZ Therapeutics Inc.Weekly Profit Summary & Daily Volume Surge Trade Alerts - Newser
Will LENZ Therapeutics Inc. bounce back from current supportWeekly Investment Recap & Smart Money Movement Tracker - Newser
Traders Consider Averaging Down in LENZ Therapeutics Inc.July 2025 Rallies & High Win Rate Trade Tips - 선데이타임즈
Developing predictive dashboards with LENZ Therapeutics Inc. data2025 Market Trends & Weekly Consistent Profit Watchlists - Newser
Full technical analysis of LENZ Therapeutics Inc. stock2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - Newser
LENZ Therapeutics Inc. Rebound Backed by Sentiment ShiftQuarterly Portfolio Summary & Real-Time Market Sentiment Reports - classian.co.kr
First Week of April 2026 Options Trading For Lenz Therapeutics - Nasdaq
Trend analysis for LENZ Therapeutics Inc. this weekJuly 2025 Review & Entry Point Confirmation Alerts - Newser
Will LENZ Therapeutics Inc. benefit from macro trendsWeekly Risk Report & Stock Market Timing Techniques - Newser
How to manage a losing position in LENZ Therapeutics Inc.Earnings Growth Report & Risk Managed Investment Entry Signals - Newser
Is a relief rally coming for LENZ Therapeutics Inc. holdersRate Hike & High Yield Equity Trading Tips - Newser
What makes LENZ Therapeutics Inc. stock price move sharplyQuarterly Performance Summary & AI Driven Price Forecasts - Newser
Has LENZ Therapeutics Inc. found a price floorWeekly Trend Report & AI Powered Market Entry Strategies - Newser
What high frequency data says about LENZ Therapeutics Inc.July 2025 Update & Weekly Stock Breakout Alerts - Newser
Using R and stats models for LENZ Therapeutics Inc. forecastingQuarterly Risk Review & Free Weekly Chart Analysis and Trade Guides - Newser
What MACD signals say about LENZ Therapeutics Inc.Portfolio Growth Summary & Community Shared Stock Ideas - Newser
Why LENZ Therapeutics Inc. stock attracts strong analyst attentionJuly 2025 Spike Watch & Expert Approved Trade Ideas - 선데이타임즈
LENZ Therapeutics Inc.’s volatility index tracking explained2025 Key Lessons & Consistent Growth Equity Picks - Newser
Short interest data insights for LENZ Therapeutics Inc.2025 Market Overview & Daily Oversold Bounce Ideas - Newser
Applying big data sentiment scoring on LENZ Therapeutics Inc.July 2025 Volume & Smart Allocation Stock Reports - Newser
What earnings revisions data tells us about LENZ Therapeutics Inc.Weekly Gains Summary & High Return Trade Opportunity Guides - Newser
No Need For Reading Glasses? Vizz Eye Drop That Improves Near Vision Has FDA Nod - NDTV Profit
Will LENZ Therapeutics Inc. rebound enough to break evenJuly 2025 Snapshot & AI Forecasted Entry/Exit Points - Newser
Using data models to predict LENZ Therapeutics Inc. stock movement2025 Breakouts & Breakdowns & Reliable Volume Spike Trade Alerts - Newser
Does LENZ Therapeutics Inc. qualify in momentum factor screeningQuarterly Profit Report & Risk Controlled Swing Alerts - Newser
Is LENZ Therapeutics Inc. a cyclical or defensive stockEarnings Performance Report & Accurate Trade Setup Notifications - thegnnews.com
Lenz Therapeutics stock hits 52-week high at 40.97 USD By Investing.com - Investing.com Canada
Lenz Therapeutics stock hits 52-week high at 40.97 USD - Investing.com
FDA Approves Vizz Eye Drops for Instant Near Vision Improvement - AInvest
Lenz Therapeutics shares rise 2.15% premarket after Lotus Pharmaceuticals reported a 6% revenue increase in the U.S. and Southeast Asia. - AInvest
What the charts say about LENZ Therapeutics Inc. todayJuly 2025 Levels & Risk Managed Investment Signals - Newser
Momentum Screeners Rank LENZ Therapeutics Inc. in Top 5 TodayAI Forecast for Trending Stocks Indicates Upside - beatles.ru
Evaluating LENZ Therapeutics Inc. with trendline analysisNeural Network Based Equity Prediction System - Newser
LENZ Therapeutics Scores Relative Strength Rating Upgrade - Investor's Business Daily
LENZ Therapeutics: Evaluate Stock Surge - timothysykes.com
LENZ Therapeutics Soars 11.6% on Explosive Intraday Rally: Technical Breakout or Speculative Surge? - AInvest
LENZ Therapeutics Soars 12.48% on Intraday Frenzy: Is This a Breakout or a Bubble? - AInvest
0.95%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):